Ophthalmology and Vision Science

Uveitis and Ocular Inflammatory Disorders

Uveitis, an intraocular inflammatory condition, can result from autoimmune, infectious, or idiopathic causes and remains a significant contributor to vision loss worldwide. Timely diagnosis using slit-lamp examination, optical coherence tomography, fundus fluorescein angiography, and laboratory investigations is crucial for preserving vision and preventing complications such as glaucoma, cataract, or retinal damage. Management strategies involve corticosteroids, immunosuppressive therapy, biologics, and targeted antimicrobial treatments depending on the underlying etiology. Challenges include differentiating between infectious and non-infectious causes, managing chronic or recurrent inflammation, and minimizing systemic side effects of long-term therapy. Emerging technologies such as artificial intelligence-assisted imaging, nanotechnology-based drug delivery systems, and point-of-care diagnostic tools are enhancing early detection, treatment precision, and patient monitoring. Regulatory oversight ensures that novel biologics, immunomodulators, and ocular devices meet global safety and efficacy standards. Current trends emphasize personalized treatment protocols, minimally invasive therapeutic interventions, and interdisciplinary collaboration between ophthalmologists, rheumatologists, and infectious disease specialists. Tele-ophthalmology platforms are increasingly used to monitor disease activity remotely, improving patient adherence and access to care in underserved regions. By integrating advanced diagnostics, targeted therapeutics, and robust regulatory compliance, the management of uveitis continues to evolve, aiming to reduce visual morbidity, improve patient quality of life, and advance research in ocular immunology globally.